FibroBiologics files patent application for in-body GLP-1 tech
FibroBiologics filed a patent application for technology intended to produce GLP-1 and other therapeutic peptides inside the body, according to Dow Jones Newswires.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
4 results loaded, newest first. End of these results.
FibroBiologics files patent application for GLP-1 technology
FibroBiologics said it filed a U.S. patent application for a cell-based technology designed to continuously produce GLP-1 and other therapeutic peptides inside the body. The company said the approach is intended as an alternative to repeated injections or pills.